Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Psoriasis duration may accelerate development of vascular disease, MACE

22 Sep 2017

Duration of psoriasis poses harmful effects on vascular inflammation and major adverse cardiovascular (CV) event (MACE), a recent study has found. This suggests that cumulative duration of exposure to low-grade chronic inflammation may fast-track vascular disease development and MACEs.

To understand the effect of psoriasis duration on vascular disease and CV events, researchers utilized two resources, namely a human imaging study and a population-based study of CV disease (CVD) events.

Patients with psoriasis (n=190) went through fludeoxyglucose F 18 positron emission tomography/computed tomography (duration effect reported as a β-coefficient). Nationwide registries were then used to examine MACE risk (adjusted hazard ratios [HRs] in patients with psoriasis: n=87,161 vs general population: n=4,234,793).

Overall, patients in the human imaging study were young, of low CV risk by traditional risk scores and had a high prevalence of cardiometabolic diseases. A significant association existed between vascular inflammation by fludeoxyglucose F 18 positron emission tomography/computed tomography and disease duration (β=0.171; p=0.002).

In the population-based study, there was a strong association between psoriasis duration and MACE risk (1.0 percent per additional year of psoriasis duration; HR, 1.010; 95 percent CI, 1.007 to 1.013).

In light of these findings, “[p]roviders should consider inquiring about duration of disease to counsel for heightened CVD risk in psoriasis,” according to researchers, adding that the use of observational data was one limitation of their study.

In another study, Harrington and colleagues stated that “[i]nflammation is known to play a significant role in the process of atherogenesis and cardiovascular disease. Indeed, patients with chronic inflammatory diseases are at increased risk for cardiovascular events.” [Am J Physiol Heart Circ Physiol 2017;312:H867-H873]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.